US 9371320
Heterocyclic compound
granted A61PA61P1/04A61P17/06
Quick answer
US patent 9371320 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/04, A61P17/06, A61P19/02, A61P25/00